foxo4-dri human trial Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI Results: What to Expect
FOXO4 DRI Results: What to Expect (2026) FOX04 DRI Apollo Peptide Sciences FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI (Proxofim) (10mg)
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




